Assessment and testing strategies

During full scale production, particularly initially, chemical reaction hazards may be reevaluated. More tests may be necessary as a consequence of increased knowledge of the process, changed production requirements, or other process changes such as the use of different feed stocks. 

A typical chronology for testing is shown on Table 1.2. The tests provide either qualitative or quantitative data on onset temperature, reaction enthalpy, instantaneous heat production as a function of temperature, maximum temperature, and/or pressure excursions as a consequence of a runaway, and 

Subject Property to Be Investigated Typical Instrument Information 

Explosibility of individual substances Detonation Deflagration Chemical structure Tube test Card gap Dropweight Oxygen balance High rate test Explosibility tests 

Compatibility Reaction with common contaminants (e.g., water) Specialized tests 

---

Interest has been expressed in the possibility of using biomarker assays as a part of risk assessment for regulatory purposes, and some workers have suggested tiered testing procedures that follow this approach (see, for example, Handy et al. 2003). It is to be hoped that regulatory schemes, such as that of REACH (see European Union 2003), will be sufficiently flexible to incorporate new assays and testing strategies as the science advances. 

The possible use of the BALB/c 3T3 CTA is mentioned in various recent testing strategies including the supplemental data for pharmaceuticals and the guidance on information requirements and chemical safety assessment for REACH [34, 35]. 

The main subject of this chapter is the identification of hazardous chemicals, materials, mixtures, and reaction masses. The chapter deals with undesired decompositions and hazardous reactions. A basic knowledge of the chemistry involved, and, in particular, with the thermodynamics and kinetics, is required. Furthermore, it is important to have a test strategy to recognize and assess the hazards associated with the energetic materials, mixtures, and reaction masses. 

Example 4 A Stability/Runaway Hazard Assessment Report In Table 2.3, test data evaluating stability/runaway hazards of a material are presented. This table contains the relevant test data and evaluations in accordance with Section 2.1.5 (Test Strategies) and represents a good model for summary reports of such key information. 

Gad, S.C. (1989b). A tier testing strategy incorporating in vitro testing methods for pharmaceutical safety assessment. Flumane Innovations and Alternatives in Animal Experimentation 3 75-79. 

From a regulatory standpoint, the FDA s concern regarding safety involves the toxicity, degradants, and impurities of excipients, as discussed in other chapters in this book. In addition, other chapters of this book address types of toxicity concerns, toxicity testing strategies, and exposure and risk assessment of excipients. 

The following is a brief explanation of some of the indicators that may be used to trigger additional definitive testing and a description of some of the most commonly used assays to assess humoral, cell-mediated, or nonspecific immune dysfunction, which are common to most immunotoxicology test strategies. 

ICH S7B Note for Guidance on the Non-clinical Evaluation for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Describes a non-clinical testing strategy for assessing the potential of a test substance to slow ventricular repolarization. Includes information concerning non-clinical assays and integrated risk assessment Anon.42... 

Component elements of the testing strategy for assessing risk for delayed ventricular repolarization and QT interval prolongation. (Source Adapted from Anon., CPMP/ICH/423/02,2005.)... 

Importantly, knowledge of intestinal bile acid transport and metabolism, coupled with increased understanding of the mechanistic basis of the pro-tumorigenic activity of bile acids against CRC cells in vitro, has recently led to development and testing of bile acid-based treatment and prevention strategies for sporadic and inflammatory bowel-disease-associated CRC. Existing evidence that manipulation of the luminal secondary bile acid pool and/or therapy with ursodeoxycholic acid (UDCA) may have promise for prevention of CRC will be assessed. 

Combes, R.D. 2000. Endocrine dismptors A critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans. ATLA 28 81-118. 

The main emphasis is paid to the identification of the basic principles for combined actions and interactions of chemicals (Section 10.2), and to the current knowledge on effects of exposures to mixtures of industrial chemicals, including pesticides and environmental contaminants. Test strategies to assess combined actions and interactions of chemicals in mixtures (Section 10.3) as well as toxicological test methods (Section 10.4) are addressed, approaches used in the assessment of chemical mixtures are presented (Section 10.5), and examples of experimental studies using simple, well-defined mixtures are given (Section 10.6). 

TEST STRATEGIES TO ASSESS COMBINED ACTIONS AND INTERACTIONS OF CHEMICALS IN MIXTURES... 

---